| Last visit was: 29 Apr 2026, 03:41 |
It is currently 29 Apr 2026, 03:41 |
|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Full Time MBA |
Admitted, ($)
|
Round 2 | 2025 | 316 GRE | 3 | 10 | Finance | Brazil |
17 Mar 2025 11:38 AM
|
| Full Time MBA |
Admitted, ($$)
|
Early Action | 2025 | 710 GMAT Classic | 4 | 4 | Real Estate | India |
17 Mar 2025 04:40 AM
|
| Full Time MBA |
Admitted from WL
|
Round 2 | 2025 | 675 GMAT Focus | 3 | Consulting | India |
15 Mar 2025 11:58 AM
|
|
| Full Time MBA |
Admitted, ($$)
|
Round 3 | 2025 | 615 GMAT Focus 640 GMAT Classic 164 EA |
3.5 | 4 | Finance: Investment Management | Thailand |
15 Mar 2025 02:41 AM
|
| Full Time MBA |
Admitted, ($$)
|
Round 1 | 2025 | 325 GRE | 3.6 | 5 | Healthcare/Pharmaceuticals | Taiwan |
14 Mar 2025 08:47 PM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 695 GMAT Focus | 8 | Finance: Investment Banking | India |
14 Mar 2025 06:54 PM
|
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 655 GMAT Focus 655 GMAT Focus 715 GMAT Focus |
3.9 | 3 | Other | China |
14 Mar 2025 12:39 PM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 695 GMAT Focus | 3.2 | 0 | Healthcare/Pharmaceuticals | India |
14 Mar 2025 10:56 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 645 GMAT Focus 685 GMAT Focus |
3.6 | 4 | Consulting | United States |
14 Mar 2025 10:47 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 695 GMAT Focus | 8 | Consulting | India |
14 Mar 2025 10:41 AM
|
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2025 | 645 GMAT Focus | 3.2 | 4 | Other | United States |
14 Mar 2025 10:36 AM
|
| Full Time MBA |
Interviewed
|
Round 2 | 2025 | 645 GMAT Focus | 3.2 | 2 | Manufacturing | Uzbekistan |
13 Mar 2025 03:03 PM
|
| Full Time MBA |
Interviewed
|
Round 1 | 2025 | 740 GMAT Classic | 3.6 | 6 | Finance | Korea, Republic of |
13 Mar 2025 01:04 AM
|
| Full Time MBA |
Denied without Interview
|
Early Action | 2025 | 10 | Consulting | United States |
12 Mar 2025 05:30 AM
|
||
| MMS FOB |
Admitted
|
2025 | 645 GMAT Focus | 7.3 | 1 | Consulting | India |
10 Mar 2025 05:37 PM
|
|
| Full Time MBA |
Interviewed
|
Round 2 | 2025 | 318 GRE | 3.5 | 7 | Other | United States |
10 Mar 2025 12:19 PM
|
| Full Time MBA |
Waitlisted without Interview
|
Round 2 | 2025 | 645 GMAT Focus | 7.8 | 8 | Consulting | India |
08 Mar 2025 02:48 AM
|
| Full Time MBA |
Interviewed
|
Round 2 | 2025 | 655 GMAT Focus | 3 | 8 | Healthcare/Pharmaceuticals | China |
05 Mar 2025 12:58 PM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 695 GMAT Focus | 7.6 | 8 | Finance: Investment Banking | India |
05 Mar 2025 05:40 AM
|
| Full Time MBA |
Denied without Interview
|
Early Action | 2025 | 5 | Finance: Investment Banking | China |
22 Feb 2025 08:05 PM
|